Hovione and Laxxon Medical Partnership Announced
Hovione and Laxxon Medical Establish an Agreement for the cGMP Production of 3D Screen Printed Pharmaceutical Applications
Hovione and Laxxon Medical Partnership Announced
Laxxon Medical to Participate in the BIO CEO & Investor Conference
Laxxon Medical to Participate in 25th Annual Needham Growth Conference
Laxxon Medical Granted U.S. Patent for the Sequential Release of Multiple Drugs
Evonik Industries and Laxxon Medical See Future In 3D Screen Printed Pharmaceuticals
3D Screen Printing Enables QR codes on Pharmaceutical Dosage Forms in Mass Production
Laxxon Medical to Participate in the 24th Annual Needham Virtual Growth Conference
Third Quarter Management Report
Scalable 3D Screen Printing - High Degree of Freedom in Terms of Drug Choice
3D Screen Printing – An Innovative Technology For Manufacturing of Pharmaceutical Dosage Forms
Laxxon Optimizes the Release of Active Substances Thanks to a Patented 3D Screen Printing Process
"Nucleus Jena" Project: First Successes Can Be Demonstrated